Centre d'investigations cliniques "cardiomet"/ CHUV
Lausanne, CH-1011, Switzerland
NCT Number: NCT00827450
This study will assess
* whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans * whether the protective effect of coffee is dependent on it's antioxidant composition
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Lausanne, CH-1011, Switzerland
Epidemiological studies suggest that coffee consumption improves glucose homeostasis in insulin resistant subjects. An increase in intrahepatic lipids (hepatic steatosis) is highly prevalent in patients with the metabolic syndrome and may be used as a marker of altered hepatic lipid metabolism. Such an increased hepatic lipids content can be experimentally produced in healthy humans by a 6-day high fructose diet.
The purpose of this study is to evaluate whether coffee prevents hepatic lipid deposition in healthy male subjects fed a fructose-rich hypercaloric diet. Both caffeine and antioxidants (yet unspecified) may be involved.. To sort out the role of caffeine and antioxidants, we will test 3 different soluble coffee, ie fully torrefied decaffeinated coffee , partially torrefied decaffeinated coffee, and partially torrefied caffeinated coffee.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Control, isocaloric diet; no coffee
Hypercaloric, high fructose diet; no coffee
Hypercaloric, high fructose diet + coffee
Hypercaloric, high fructose diet + coffee
Hypercaloric, high fructose diet + coffee
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
University of Lausanne
Other
Effects of Coffees With Various Compositions of Antioxidants on Hepatic Steatosis Induced by a High Fructose, Hypercaloric Diet
Acronym: COLIBRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06352697
Digestive System Diseases, Fatty Liver
Kyiv, Ukraine
View Trial DetailsNCT05804422
Body Weight, Digestive System Diseases
Kyiv, Ukraine
View Trial DetailsNCT06940375
Digestive System Diseases, Fatty Liver
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07103603
Digestive System Diseases, Fatty Liver
Istanbul, Beyoğlu, Turkey (Türkiye)
View Trial Details